Phoebe Xi
Counsel Trademark Agent Patent Attorney

Phoebe Xi is a Patent Counsel and the leader of the Bio-Chemistry Group at Chang Tsi & Partners. With a career in patent law that began in 2011, she has developed deep expertise in the field and has been an invaluable asset to our firm since 2014.

Phoebe’s experience spans a wide range of patent-related activities, including drafting and prosecuting patent applications, navigating challenges and defenses before the Patent Reexamination Board, representing clients in oral proceedings at the Invalidation Board, managing patent portfolios, and developing strategic patent filing plans.

Her professional expertise covers a broad array of industries, including bio-chemistry, pharmaceuticals, and chemical engineering. Phoebe excels in specialized fields such as clean energy, small molecule and macromolecular drugs, diagnostics, and food-related technologies, demonstrating her proficiency in these areas.

Prior to joining Chang Tsi, Phoebe gained valuable experience working for three years in the R&D department of one of China’s leading energy companies, further enriching her knowledge and understanding of the industry.

+86 10 88369999
Patent Prosecution
Beijing

Practice Focus

Technical field

  • Pharmaceutical Research and Development
  • Genetic Technology
  • Biotechnology
  • Organic Chemistry
  • Inorganic Chemistry
  • Polymer Chemistry
  • Environmental Chemistry
  • Renewable Energy
  • Energy-Saving Technology
  • Environmental Protection
  • Water Treatment Technology
  • Bioagriculture
  • Food Science
  • Aquaculture

Years with IP Matters

  • 2011 until now 

Education

  • Master of Science in Physical Chemistry, Taiyuan University of Technology (2008)
  • Bachelor of Bioengineering, Inner Mongolia University of Technology (2005)

Professional Experience

  • Counsel,Patent Attorney, Chang Tsi & Partners, 2014 - Present
  • Patent Attorney, Jeekai & Partners, 2011 - 2014
  • R&D engineer, Patent Principal, Xinao Group, 2008 - 2011

Representative Clients

  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • BOSTIK, INC.
  • TOTAL MARKETING SERVICES
  • RICH PRODUCTS CORPORATION
  • L'OREAL
  • MacroGenics, Inc.
  • CEMPRA PHARMACEUTICALS, INC.

Representative Cases

  • In a case where the examiner intended to reject the application of her client, Xi was able to successfully prove to the examiner the unexpected treatment effect obtained by the compound in the application, and finally obtained the grant of the patent. In light of this excellent work, the client transferred their remaining applications to our law office.
  • In patent reexamination cases for an American chemical company, Xi successfully and repeatedly obtained approval by the Patent Reexamination Board.

Bar Admission

  • Chinese Patent Bar (2015)
  • Chinese Patent Agent Ad Litem (2019)

Languages

  • Mandarin Chinese
  • English